Dubai Health Authority signs MoU with VPS Healthcare

Dubai Health Authority and UAE based VPS Healthcare signed a memorandu...

December 6, 2019 | Friday | News
Screen Therapeutics partners with Immunaccel for immuno-oncology drug development

Screen Therapeutics LLC has formed a partnership with Immunaccel to fo...

December 6, 2019 | Friday | News
FDA launches app to report novel uses of existing medicines

The U.S. Food and Drug Administration has announced the global launch ...

December 9, 2019 | Monday | News
Malaria on the decline in WHO South-East Asia Region: WHO

As WHO South-East Asia Region continues to register a steep decline in...

December 4, 2019 | Wednesday | News
AstraZeneca to sell rights of anti-psychotic drug to Cheplapharm

AstraZeneca, a global, science-led biopharmaceutical company has agree...

December 4, 2019 | Wednesday | News
Philips introduces next-gen enterprise imaging solution

Royal Philips, a global leader in health technology, introduced its ne...

December 3, 2019 | Tuesday | News
GE Healthcare brings novel solution for mammography

To help empower clinicians and patients in their fight against breast ...

December 2, 2019 | Monday | News
Elsevier acquires creator of 3D anatomy technology

Elsevier, a global information analytics business specializing in scie...

November 29, 2019 | Friday | News
FDA grants priority review to Roche’s risdiplam for SMA

Roche has announced that the U.S. Food and Drug Administration (FDA) h...

November 28, 2019 | Thursday | News
Lonza collaborates with DiNAQOR AG to advance gene therapy programs

Lonza and DiNAQOR AG, a global gene therapy platform company, have ann...

November 27, 2019 | Wednesday | News
Alkermes completes acquisition of Rodin Therapeutics

Ireland based Alkermes plc has completed its previously announced acqu...

November 25, 2019 | Monday | News
Novartis to acquire The Medicines Company for $9.7 B

Novartis has announced that it has entered into an agreement and plan ...

November 26, 2019 | Tuesday | News
CNS Pharma acquires brain cancer drug rights from Houston Pharma

CNS Pharmaceuticals, a biotechnology company specializing in the devel...

November 22, 2019 | Friday | News
Cholesterol lowering drugs may cut risk of lethal prostate cancer

New research led by Queen’s University Belfast has found that me...

November 22, 2019 | Friday | News
Bristol-Myers Squibb completes acquisition of Celgene

Bristol-Myers Squibb Company has announced that it has completed its a...

November 21, 2019 | Thursday | News
MC2 Therapeutics’s wynzora cream gets FDA nod to treat Plaque Psoriasis

MC2 Therapeutics, an emerging pharmaceutical company focused on novel ...

November 21, 2019 | Thursday | News
Azeria Therapeutics announces £32.0 M series B financing

Azeria Therapeutics (Azeria), a newly formed pioneer factor drug disco...

November 21, 2019 | Thursday | News
FDA approves Pfizer’s biosimilar for multiple inflammatory conditions

Pfizer Inc. has announced the United States (U.S.) Food and Drug Admin...

November 20, 2019 | Wednesday | News

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy